ArticleMedComm2026

Low Dose of IL-2 Application for Graft-Versus-Host Disease Prophylaxis Following Haploidentical Stem Cell Transplantation.

Zheng-Li Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.